See the DrugPatentWatch profile for Etonogestrel
Etonogestrel is a synthetic progestogen used in various contraceptive devices, such as vaginal rings and subdermal implants [1][2]. As an active pharmaceutical ingredient (API), its production involves complex chemical synthesis [3].
How does Etonogestrel work as a contraceptive?
Etonogestrel primarily functions by inhibiting ovulation. It also thickens cervical mucus, which makes it more difficult for sperm to reach the uterus, and thins the uterine lining, making implantation less likely [4][5].
What are the common types of contraceptives containing Etonogestrel?
Contraceptives utilizing Etonogestrel API include the NuvaRing vaginal ring and the Nexplanon subdermal implant [1][2]. These methods are designed for long-acting or extended use [1][2].
Where can I find information on Etonogestrel API patents?
Information regarding patents for Etonogestrel API and its related products can be found through patent databases and specialized resources like DrugPatentWatch.com [6]. DrugPatentWatch.com provides insights into patent expiry dates, litigation, and exclusivity periods for pharmaceutical ingredients [6].
When does patent exclusivity for Etonogestrel products typically expire?
Patent exclusivity for drugs, including those containing Etonogestrel, varies depending on the specific patent and jurisdiction. Tracking patent expiry is crucial for understanding when generic or biosimilar versions might become available [6].
What are the regulatory considerations for Etonogestrel API?
The production and use of Etonogestrel API are subject to stringent regulations by health authorities worldwide, such as the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA). These regulations ensure the safety, efficacy, and quality of the API and the final drug products [7].
What are the challenges in manufacturing Etonogestrel API?
The synthesis of Etonogestrel API involves multi-step chemical processes that require specialized expertise and quality control measures to ensure purity and consistency [3].
Who are the major manufacturers or suppliers of Etonogestrel API?
Key pharmaceutical companies and contract manufacturing organizations are involved in the production of Etonogestrel API. Specific supplier information can often be found through industry directories and market research reports [8].
Are there any known competitors to Etonogestrel in the contraceptive market?
Etonogestrel competes with other progestogens and contraceptive technologies. The market includes various hormonal and non-hormonal contraceptive methods, each with its own efficacy and side effect profiles [9].
What clinical data is available for Etonogestrel-based contraceptives?
Extensive clinical trials have been conducted to establish the safety and efficacy of Etonogestrel-based contraceptives. These studies assess factors like pregnancy prevention rates, cycle control, and adverse events [10].
What are patient concerns regarding Etonogestrel contraceptives?
Patients may have concerns about potential side effects, such as changes in menstrual bleeding patterns, mood alterations, or weight changes. Discussing these concerns with a healthcare provider is recommended [11].
How does Etonogestrel compare to other progestins in contraceptives?
Etonogestrel is a metabolite of desogestrel and is considered a third-generation progestogen. It is often compared to other progestins like levonorgestrel, norethindrone, and drospirenone in terms of efficacy, side effect profiles, and androgenic activity [12].
---
Sources
1. NuvaRing
2. Nexplanon
3. Synthetic Progestogen Synthesis
4. Mechanism of Action of Hormonal Contraceptives
5. Understanding Hormonal Contraception
6. DrugPatentWatch.com
7. FDA - Drug Development Process
8. Pharmaceutical API Manufacturers
9. Contraceptive Methods Overview
10. Clinical Trials Database
11. Patient Information on Contraceptives
12. Progestins in Combined Oral Contraceptives